177 related articles for article (PubMed ID: 22714006)
1. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis.
Salm LP; Van der Hiel B; Stokkel MP
Nucl Med Commun; 2012 Sep; 33(9):907-16. PubMed ID: 22714006
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
[TBL] [Abstract][Full Text] [Related]
4. Neurolymphomatosis as a late relapse of non-Hodgkin's lymphoma detected by 18F-FDG PET/CT: a case report.
Kajáry K; Molnár Z; Mikó I; Barsi P; Lengyel Z; Szakáll S
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):39-42. PubMed ID: 23683830
[TBL] [Abstract][Full Text] [Related]
5. The role of 18F-FDG PET/CT in Neurolymphomatosis: A Comprehensive Imaging Approach.
Usmani S; Jain A; Riyami KA; Ahmed N; Al-Sukaiti R; Shamim MS
J Pak Med Assoc; 2024 Apr; 74(4):822-824. PubMed ID: 38751291
[TBL] [Abstract][Full Text] [Related]
6. Neurolymphomatosis: MRI and (18) FDG-PET features.
Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
[TBL] [Abstract][Full Text] [Related]
7. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
Jeong J; Kim SW; Sung DH
J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
[TBL] [Abstract][Full Text] [Related]
8. F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy.
Suga K; Yasuhiko K; Matsunaga N; Yujiri T; Nakazora T; Ariyoshi K
Clin Nucl Med; 2011 Jan; 36(1):73-6. PubMed ID: 21157220
[TBL] [Abstract][Full Text] [Related]
9. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Lin M; Kilanowska J; Taper J; Chu J
Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
[TBL] [Abstract][Full Text] [Related]
10. Neurolymphomatosis diagnosed by (18)F-FDG PET-CT.
Salm LP; Van der Hiel B; Stokkel MP
Clin Nucl Med; 2013 Jun; 38(6):e261-2. PubMed ID: 22996248
[TBL] [Abstract][Full Text] [Related]
11. An Extremely Rare Intersection: Neurolymphomatosis in a Patient with Burkitt Lymphoma Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Oner AO; Okuyucu K; Alagoz E; Battal B; Arslan N
World J Nucl Med; 2016 Sep; 15(3):209-11. PubMed ID: 27651745
[TBL] [Abstract][Full Text] [Related]
12. Neurolymphomatosis in a patient with extranodal NK/T-cell lymphoma, nasal-type: a case report and literature review.
Shimizu I; Hamano Y; Sato S; Takeda W; Kirihara T; Sato K; Ueki T; Hiroshima Y; Sumi M; Ueno M; Ichikawa N; Kobayashi H
Intern Med; 2014; 53(5):471-5. PubMed ID: 24583438
[TBL] [Abstract][Full Text] [Related]
13. Bilateral vagus nerve neurolymphomatosis diagnosed using PET/CT and diffusion-weighted MRI.
Gs B; J G; LA Mde S; Pg G; Cv A; Fv P; Em B; Ets B
Clin Nucl Med; 2012 Sep; 37(9):e225-8. PubMed ID: 22889798
[TBL] [Abstract][Full Text] [Related]
14. Neurolymphomatosis detected by (18)F-FDG PET/CT scan - a case report.
Czepczyński R; Guzikowska-Ruszkowska I; Sowiński J
Nucl Med Rev Cent East Eur; 2008; 11(2):73-5. PubMed ID: 19585459
[TBL] [Abstract][Full Text] [Related]
15. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
17. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
19. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.
Kanter P; Zeidman A; Streifler J; Marmelstein V; Even-Sapir E; Metser U; Stein GY; Cohen AM
Eur J Haematol; 2005 Jan; 74(1):66-9. PubMed ID: 15613109
[TBL] [Abstract][Full Text] [Related]
20. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]